Historical Setting and Architecture

Hong Kong’s over-the-counter (OTC) derivatives reform forms part of the post-global-financial-crisis programme to improve transparency, reduce counterparty risk and strengthen market infrastructure. The legislative architecture was built principally through the Securities and Futures Ordinance (SFO), as amended by the Securities and Futures (Amendment) Ordinance 2014, together with subsidiary legislation governing reporting, clearing, trading, record-keeping and related compliance obligations. Joint administration by the Securities and Futures Commission (SFC) and Hong Kong Monetary Authority (HKMA) is central to the design of the regime because the affected market includes both SFC-licensed corporations and authorised institutions (AIs).

The framework has developed in stages: mandatory reporting became operational first, mandatory clearing followed on a narrower product and counterparty basis, margin and other risk mitigation requirements for non-centrally cleared OTC derivatives were developed through the conduct and prudential framework, and the bespoke licensing and capital architecture for OTC derivatives activities has remained the longest-developing limb of the reform package.

Two principal pieces of currently operational subsidiary legislation are:

• the Securities and Futures (OTC Derivative Transactions – Reporting and Record Keeping Obligations) Rules, Cap. 571AL, which impose reporting obligations under Section 101B of the SFO and related record-keeping obligations under Section 101E (the “Reporting Rules”); and
• the Securities and Futures (OTC Derivative Transactions – Clearing and Record Keeping Obligations and Designation of Central Counterparties) Rules, Cap. 571AN, which implement the clearing obligation under Section 101C, related record-keeping obligations under Section 101E, and the designation of central counterparties under Section 101J (the “Clearing Rules”).

The regime is best viewed through five regulatory levels:

• mandatory reporting;
• mandatory clearing;
• statutory trading-obligation architecture;
• conduct and risk mitigation obligations for uncleared transactions; and
• prudential or licensing consequences for firms carrying on OTC derivatives business.

Although Hong Kong’s live OTC derivatives compliance burden has centred mainly on reporting, clearing, risk mitigation and margin, the statutory architecture also contains a trading obligation framework, and regulators have adopted a trading determination process for assessing whether particular products should become subject to platform trading requirements. Firms should therefore monitor trading-obligation determinations even though this has not yet become the principal operational burden for most SFC-regulated groups.

For most SFC-regulated groups, the live issues now are Hong Kong Trade Repository (HKTR) reporting, clearing threshold monitoring, affiliate and booking-model governance, uncleared margin and risk mitigation controls, and the prospective capital effect of the Financial Resources Rules (FRR) changes and proposed Type 11 and Type 12 regulated activities framework under the SFO and its sub-legislation.

Licensing Reform and Scope of Regulated Activities

At the time of publication of this guide, the dedicated OTC derivatives licensing regime introduced by the Securities and Futures (Amendment) Ordinance 2014 includes Type 11 and Type 12 regulated activities. The SFC’s current licensing materials list Type 11 as “dealing in OTC derivative products or advising on OTC derivative products” and Type 12 as “providing client clearing services for OTC derivative transactions”, but both are marked as “not yet in operation”.

That does not reduce their practical importance. The policy design is sufficiently advanced that groups should already assess whether their present business would fall within the to-be-expanded Type 7, Type 9, Type 11 or Type 12. The SFC’s 2025 OTC derivatives activities survey expressly targeted firms whose activities would fall within expanded Type 7, Type 11 or Type 12 when the licensing regime introduced by the 2014 Amendment Ordinance comes into effect.

The reform also contemplates transitional arrangements. The SFC has previously indicated that there would be a six-month grace period from commencement of the OTC derivatives licensing regime, during which market participants may continue activities falling within the new or expanded regulated activities without relevant licences or registrations. This does not mean firms can wait passively. In practice, the grace period is designed to manage commencement, not to replace advance entity mapping, responsible officer planning, systems readiness and capital analysis.

Expanded Type 7 and Type 9

Expanded Type 7 is relevant where automated trading services involve OTC derivative transactions or products. Expanded Type 9 is relevant where the management of portfolios of OTC derivative transactions falls within scope. This captures firms performing ATS or asset management functions who may not be conventional front-office dealers or advisers but become regulated once the OTC derivatives licensing regime is commenced.

Asset managers whose derivatives activities go beyond hedging incidental to traditional securities or futures portfolios, may face specific OTC derivatives portfolio-management licensing analysis, subject to applicable exemptions, including where OTC derivatives portfolio management is wholly incidental to OTC derivatives dealing activities in specified circumstances. Similarly, platform operators and infrastructure providers should not assume that their analysis ends with Type 11 or Type 12; expanded Type 7 may become equally important where automated matching, execution, routing or trading functionality is involved.

Type 11

The proposed Type 11 regulated activity is intended to cover dealing in, and advising on, OTC derivative transactions. The dealing limb includes entering into or offering an OTC derivative transaction and inducing or attempting to induce another person to enter into or offer such a transaction; the advising limb includes advising or issuing reports or analyses on whether derivative transactions should be entered into or on the terms on which they should be entered into.

Type 11 is significant in that Type 1 and Type 4 regimes only capture part of the derivatives landscape, principally where the relevant product falls within the definition of securities. Many OTC derivatives businesses, including significant commodities derivatives and interest rate swap activity, do not fall within those categories, which is why the Type 11 perimeter is a major issue for firms using Hong Kong entities for marketing, execution support, structuring or client advice on non-securities OTC products.

Some exemptions relied on in existing business models, including principal-to-principal analysis under Type 1, may not survive once the OTC derivatives-specific regime is implemented. The practical analysis should therefore be undertaken by activity, product, counterparty, booking entity and client-contact function, rather than by assuming that existing Type 1 or Type 4 conclusions will automatically carry across.

Type 12

The proposed Type 12 regulated activity is intended to capture the provision of clearing and settlement services for OTC derivative transactions. For many groups, the immediate importance of Type 12 is not current licensing exposure but preparatory entity mapping: identifying which group company actually handles client clearing, post-trade processing, settlement support or intragroup facilitation in a manner that may later fall within Type 12.

This should be read together with the clearing regime and FRR proposals. A firm that provides client clearing services may face licensing obligations as well as capital, client-asset, disclosure, portability, segregation and operational resilience expectations. The commercial question is therefore not simply whether a Hong Kong entity can obtain Type 12 approval, but whether it can maintain the infrastructure, governance and capital base required for that activity on a sustainable basis.

Conduct Reform and Affiliate Structures

The conduct reforms are commercially significant because they are directed at common cross-border operating models. In particular, the regulated client-facing affiliate requirement addresses the practice under which a Hong Kong licensed corporation solicits or advises a client but the transaction is actually entered into with an overseas or other group affiliate.

The SFC’s consultation materials confirmed a regulated client-facing affiliate framework (the “Regulated CFA”). Broadly, where a licensed corporation introduces clients to group affiliates for OTC derivative transactions, the CFA must fall within the prescribed regulated categories, including licensed corporations, authorised financial institutions or comparable overseas-regulated entities, subject to the regulated client exemption, disclosure requirements, best-interest obligations and transitional arrangements for existing arrangements. A professional investor (PI) is not automatically a regulated client, and PI status does not by itself displace the regulated client analysis. For legacy arrangements, transitional treatment applies to existing client-facing affiliates, so the rule is not an immediate prohibition on all pre-existing structures.

A licensed corporation may therefore introduce a client to enter into an OTC derivative transaction with a group affiliate only where the affiliate falls within the relevant regulated categories, or where an applicable exemption or transitional arrangement applies. This requirement is exempted for OTC derivative transactions entered into with a regulated client, but the regulated client exemption does not apply merely because the client is a PI. The SFC rejected the proposition that PIs should automatically be treated as equivalent to regulated clients, because PI status does not necessarily mean the person is subject to regulatory standards comparable to those applicable to regulated client-facing affiliates.

The transitional period for the Regulated CFA Requirement lasts until the end of the transitional period for Type 11 regulated activity. During that transitional period, licensed corporations may continue to introduce clients to those existing affiliates, but they must implement reasonable measures to protect clients from conduct and prudential risks. This is an important qualification because it means that the rule should not be read as an immediate prohibition on every legacy unregulated affiliate arrangement, but a conduct-risk control which requires the licensed corporation to justify and manage the arrangement.

This is a major pressure point for remote booking models. Where Hong Kong staff perform the economically meaningful client-facing functions but the transaction is documented with an offshore affiliate selected primarily for balance sheet or capital reasons, the group needs to assess whether the affiliate is sufficiently regulated, and whether the overall structure remains coherent once the future Type 11 perimeter, conduct rules and prudential expectations are read together.

The oversight of unregulated risk-booking affiliates creates a related but distinct obligation. The SFC’s conclusions describe the risk-booking affiliate obligation as applying where a licensed corporation arranges OTC derivative transactions entered into with its clients, or back-to-back against client transactions, for group affiliates that are not licensed corporations, authorised financial institutions or similarly regulated OTC derivative dealers or banks. The licensed corporation should consider SFC guidance and relevant group or risk-booking affiliate regulator guidance when designing risk management programmes.

In practice, this means intra-group booking is no longer simply a treasury or middle-office decision; it becomes a governance issue requiring demonstrable alignment between local controls, group risk appetite, desk mandates and escalation arrangements. A licensed corporation should review its own risk policies and ensure that risks taken by the risk-booking affiliate are subject to risk management standards consistent with those expected by relevant regulators.

The practical issue is not merely when a rule takes effect, but whether a target operating model can withstand scrutiny where Hong Kong originates or negotiates trades while another entity books the trade, holds the risk and bears the capital cost. That model is especially exposed where the affiliate is not independently regulated, where governance documentation is weak, or where the Hong Kong entity cannot evidence meaningful oversight of the conduct and prudential risks created by the structure.

Mandatory Reporting and HKTR Developments

Mandatory reporting is the most developed limb of Hong Kong’s OTC derivatives regime. The Reporting Rules first took effect on 10 July 2015, initially covering certain interest rate swaps and non-deliverable forwards, and were later expanded to all specified OTC derivatives. In September 2024, the HKMA and SFC concluded on a more internationally standardised reporting framework requiring Unique Transaction Identifiers (UTI), Unique Product Identifiers (UPI), Critical Data Elements (CDE) and ISO 20022 XML, implemented on 29 September 2025. HKTR’s operating and technical materials have since been updated to reflect the ISO 20022 reporting environment. Firms should treat reporting as a systems-and-governance issue rather than a purely filing obligation.

A further 2026 operational update is important. HKTR announced on 5 March 2026 that live legacy transactions with a remaining maturity of more than one year as of 29 September 2025 had to be re-reported in ISO format within a six-month transitional period ending on 29 March 2026, marking the lapse of the key long-dated legacy migration deadline.

Practically, reporting compliance now depends on data lineage, control over UTI generation and sharing, product classification, life cycle-event reporting, valuation logic, error remediation and system capability to submit in the required XML format. In other words, the reporting obligation is now inseparable from systems architecture and operational governance.

That has several consequences for licensed corporations.

• First, booking architecture matters because it affects who has the source data needed for accurate reporting.
• Second, intra-group arrangements and third-party vendor contracts should clearly allocate responsibility for UTI creation, data quality, validation breaks and correction workflows.
• Third, legacy-trade migration and post-go-live exception management should be treated as continuing legal-compliance issues rather than one-off technology tasks.

Masking relief should also be noted. The March 2024 consultation explained that Rule 26(1) of the Reporting Rules permits masking of counterparty information where reporting is prohibited in designated jurisdictions, and regulators concluded that no change would be made to the current designated list. This is a narrow relief rather than a general exception, and firms relying on it should maintain legal analysis and evidence showing why disclosure is prohibited in the relevant jurisdiction.

Mandatory Clearing and Recent Refinements

Mandatory clearing in Hong Kong continues to operate on a targeted basis under the Clearing Rules. It applies by reference to prescribed persons, specified product classes, thresholds and designated central counterparties, rather than imposing universal clearing across the OTC derivatives market.

The clearing obligation under the Clearing Rules is threshold-based. A prescribed person becomes subject to the obligation once its applicable average local total position in relevant OTC derivative transactions during the relevant calculation period reaches the prescribed threshold, currently USD20 billion. From that point, relevant transactions entered into on or after the prescribed day must be centrally cleared.

The clearing framework is responsive to market developments, benchmark reform and clearing-house product specifications, and continues to be refined through periodic regulatory updates. In August 2023, the HKMA and the SFC concluded consultation on amendments to the Clearing Rules, including changes to floating rate option terms for certain interest rate swap classes affected by benchmark reform.

In June 2025, the HKMA and the SFC concluded the annual update to the Financial Services Providers (FSPs) list for the clearing regime. The updated FSP list was later gazetted and took effect on 1 January 2026. The SFC also reminded licensed persons that, where their average total position during a calculation period reaches the clearing threshold, relevant transactions entered into on or after the prescribed day, including transactions with FSPs, must be centrally cleared.

That annual update is not merely administrative. For firms near the clearing threshold, or firms that frequently transact with global dealers, changes to the FSP list may affect whether particular counterparties are included in the calculation mechanics relevant to the clearing obligation. Threshold monitoring should therefore be treated as an ongoing legal and compliance issue, rather than a one-off onboarding check.

The 2026 annual FSP review should also be noted. The HKMA and the SFC confirmed in April 2026 that there would be no change to the FSP list, but firms should maintain annual reviews as practical consequences of the clearing regime continue to depend on FSP designations and applicable calculation-period mechanics.

The January 2026 consultation on standard calculation periods has also been concluded. On 5 June 2026, the HKMA and the SFC issued consultation conclusions confirming broad support for standardising calculation periods under the Clearing Rules. They intend to proceed with legislative amendments so that, from 1 March 2027, the calculation periods will be standardised as 1 March to 31 May and 1 September to 30 November each year, reducing the need for repeated amendments to Schedule 2.

Risk Mitigation and Margin for Uncleared Transactions

Three related but distinct frameworks are involved here: SFC risk mitigation requirements, SFC margin requirements, and HKMA margin and risk mitigation standards for AIs.

SFC risk mitigation requirements

The SFC’s risk mitigation requirements apply to licensed corporations that enter into OTC derivative transactions, as well as to certain Type 9 asset managers in respect of OTC derivative transactions entered into on behalf of collective investment schemes, except where such transactions are handled by the governing body of the scheme or its delegate. The SFC’s requirements cover trading relationship documentation, trade confirmation, valuation, portfolio reconciliation, portfolio compression and dispute resolution.

The purpose of these requirements is to reduce legal uncertainty, operational risk and dispute risk in uncleared derivatives trading. The SFC does not prescribe a single mandatory form of documentation; rather, the key point is that legal certainty should be reviewed over time and not treated as a one-off onboarding exercise. Firms should periodically assess whether their master agreements, credit support documentation, confirmations, valuation processes and dispute-resolution mechanisms remain enforceable and operationally effective.

This matters because “uncleared” does not mean “lightly regulated”. Firms that choose, or are required, to remain outside central clearing must still maintain robust documentation, collateral, reconciliation, compression and dispute-management infrastructure. In practice, these obligations affect documentation strategy, collateral operating-model design, and the allocation of responsibility among front office, legal, operations, risk and collateral-management teams.

SFC margin requirements

The SFC’s margin requirements under Part III of Schedule 10 to the Code of Conduct apply to licensed persons that enter into non-centrally cleared OTC derivative transactions with covered entities, subject to the relevant counterparty classifications, average aggregate notional amount (AANA) thresholds, product scope, exemptions and substituted compliance. The regime requires the exchange of both initial margin (IM) and variation margin (VM) in the circumstances specified by the rules.

For IM, a licensed person must exchange IM on a gross basis with a covered entity in accordance with the implementation schedule. The rules permit the parties to agree not to exchange IM where the amount due is equal to or below HKD375 million, and that threshold is applied at the level of the relevant consolidated groups.

For VM, a licensed person must exchange VM with a covered entity where the licensed person or its consolidated group has an average aggregate notional amount of OTC derivatives exceeding HKD15 billion, subject to the higher HKD60 billion threshold for the instruments specified in paragraph 7(b). VM is intended to fully collateralise current exposure arising from changes in the mark-to-market value of the relevant transactions.

Substituted compliance is also important for cross-border groups. The SFC’s comparable jurisdiction framework permits a licensed person, in specified circumstances, to elect to follow a counterparty’s comparable foreign margin requirements instead of the SFC requirements, provided that the licensed person has notified the SFC and the relevant foreign requirements are deemed or determined comparable, subject to SFC conditions.

HKMA CR-G-14

For AIs, the HKMA’s Supervisory Policy Manual module CR-G-14, “Non-centrally Cleared OTC Derivatives Transactions – Margin and Other Risk Mitigation Standards” (the “Margin Rules”), is the key reference point. The HKMA describes CR-G-14 as setting minimum standards for AIs in respect of margin and other risk mitigation standards for non-centrally cleared OTC derivatives. It covers margin standards and risk mitigation techniques including trading relationship documentation, trade confirmation, valuation, portfolio reconciliation, portfolio compression and dispute resolution.

CR-G-14 matters because Hong Kong’s OTC derivatives regime must be understood through both the HKMA and SFC frameworks, depending on the nature of the entity and the transaction. Many group structures involve both an SFC-licensed corporation and an authorised institution, or involve trading with AIs as counterparties. A proper operating-model review should therefore map the applicable HKMA and SFC requirements and confirm that documentation, collateral, valuation and reconciliation processes are aligned with the relevant regime(s).

FRR Reform and Prudential Consequences

The Financial Resources Rules are where the OTC derivatives reform becomes strategically decisive for SFC-regulated entities. Following the 2017 consultation, the SFC launched a further public consultation on 14 July 2025 on draft amendments to the FRR and related guidelines for internationally comparable capital requirements for licensed corporations engaging in OTC derivative activities, together with other changes to facilitate market development.

At the time of publication of this guide (1 September 2026), the FRR amendments are in final consultation stage. The English draft consultation closed on 13 October 2025, and the Chinese version consultation closed on 6 February 2026, but the final commencement date is still pending SFC publication of the final conclusions.

The July 2025 proposals build on the 2017 framework by moving the regime closer to revised Basel standards, including updated approaches for market risk, counterparty credit risk and credit valuation adjustment (CVA) risk. More broadly, they shift capital treatment from a product-based to a more risk-sensitive model, making netting, booking structure and clearing profile more important for back-to-back and principal-based businesses.

The proposed FRR framework continues to distinguish OTC derivatives dealers by business model and risk profile, with the heaviest capital burden falling on non-cleared dealing businesses and lighter treatment for cleared, advisory or limited models. The proposed figures are commercially material. For example, the 2025 consultation indicates:

• HKD30 million paid-up share capital and HKD15 million floor required liquid capital (RLC) for OTC derivatives dealing cleared by regulated CCP only;
• HKD60 million paid-up share capital and HKD30 million floor RLC for OTC derivatives inter-dealer broker only;
• HKD500 million tangible capital and HKD78 million floor RLC for a general OTC derivatives dealer below specified thresholds;
• HKD1 billion tangible capital and HKD156 million floor RLC for other general OTC derivatives dealers;
• HKD1 billion tangible capital and HKD195 million floor RLC for Type 12 OTC derivatives clearing below specified thresholds;
• HKD100,000 floor RLC for Type 9 OTC derivatives asset management with no client assets; and
• HKD5 million paid-up share capital with HKD3 million floor RLC for other Type 9 OTC derivatives asset management models.

These figures explain why the licensing reform cannot be analysed in isolation. The decisive question for many groups is not merely whether an activity may require a Type 11 licence when the regime commences, but whether the Hong Kong entity can justify the resulting prudential cost, especially for non-cleared dealing businesses. The capital burden is influential to entity selection, product scope, client segmentation, transfer-pricing assumptions and even the commercial viability of maintaining certain OTC products within an SFC-licensed platform.

The consultation also gives attention to CVA and internal models. The SFC proposes a simplified CVA substitute approach under which, for users of the simplified OTC derivatives counterparty credit risk approach, the CVA risk charge would equal the counterparty credit risk capital requirement on the same OTC derivative transactions. The SFC may require a licensed corporation with total OTC derivatives positions exceeding HKD1 trillion to use the Basel CVA framework. This is significant because CVA risk is not merely an accounting concept; it becomes a prudential capital issue capable of affecting pricing, booking and counterparty selection.

The consultation gives significant attention to internal models and model risk management, allowing the use of internal models subject to approval and strict governance, documentation, validation and stress-testing standards. The draft model risk management principles state that a covered licensed corporation’s board is ultimately responsible for model risk management and should establish a comprehensive firm-wide model risk management framework, with policies covering model development, implementation, validation, revalidation, periodic review, governance, challenge and documentation.

The broader point is that internal model approval is not just a technical or quantitative exercise. It also depends on a firm’s governance structure, documentation quality, validation rights, independent challenge, audit access and ability to demonstrate reliable capital calculation. For groups relying on vendor models, group models or offshore quantitative teams, the Hong Kong licensed corporation will need to show that it has sufficient oversight and access to satisfy local regulatory expectations.

Taken together, the reforms indicate a move towards a more granular and risk-sensitive regime that better reflects how derivatives risk is managed across products and markets. The overall direction is towards closer alignment between prudential capital treatment and actual trading risk, but that alignment will also make booking structures, clearing decisions, netting enforceability and collateral arrangements more commercially consequential.

Practical Implications for Licensed Corporations

Several practical themes emerge from the present state of reform.

• Booking-model pressure remains intense. The combined effect of the regulated CFA requirement, oversight of unregulated risk-booking affiliates, the future Type 11 perimeter and the FRR capital proposals place sustained pressure on remote booking structures that separate Hong Kong client origination from offshore execution and risk ownership.
• Reporting compliance has become a data-governance exercise as much as a legal one. The move to UTI, UPI, CDE and ISO 20022 XML reporting means that firms must understand, document and control the provenance of reportable data across front-office systems, confirmations, life cycle-event processing, collateral records and HKTR submission tools. The enhanced reporting regime is already live, and the long-dated legacy migration deadline has already passed.
• Clearing-threshold monitoring should be treated as a continuing regulatory obligation. Annual FSP-list updates, technical refinements to the Clearing Rules and the forthcoming standardised calculation periods can alter whether trades with particular counterparties become caught, even where the firm’s core product set has not materially changed. From 1 March 2027, subject to completion of the legislative process, calculation periods are expected to be standardised as 1 March to 31 May and 1 September to 30 November each year.
• Capital analysis must be undertaken at business-model level rather than as a purely legal classification exercise. A group that can technically perform the relevant activity through a Hong Kong licensed corporation may still decide that the associated capital charges, governance upgrades and model-risk requirements render a different legal-entity structure commercially preferable.
• Governance evidence matters. Boards, responsible officers and control functions should expect scrutiny not just of legal conclusions but of desk mandates, product approvals, intra-group agreements, delegation arrangements, reporting controls, model-governance materials and documentary evidence showing who actually solicits, advises, negotiates, books and risk-manages the transaction.
• Uncleared derivatives should be treated as a control-intensive business. Even where a product is not centrally cleared, the firm must still address SFC risk mitigation requirements, SFC margin requirements where applicable, and Margin Rules where AIs are involved. Documentation, collateral, valuation, reconciliation, compression and dispute-management processes should therefore be tested as part of the operating model rather than treated as back-office implementation details.
• Firms should continue to monitor the trading-obligation framework even though it has not yet become the principal compliance burden. The statutory architecture includes reporting, clearing, trading and record-keeping, and future trading determinations could affect platform usage, execution processes and client documentation.

Conclusion

As of now, Hong Kong’s OTC derivatives regime is operationally mature but structurally incomplete. Mandatory reporting and clearing are live, with HKTR reporting materially enhanced through UTI, UPI, CDE and ISO 20022 requirements. The long-dated legacy trade migration period ended on 29 March 2026. Mandatory clearing remains targeted and threshold-based, with the clearing threshold currently set at USD20 billion and with standardised calculation periods expected to apply from 1 March 2027 following the June 2026 HKMA-SFC conclusions.

The Type 11 and Type 12 licensing regime and expanded Type 7 and Type 9 perimeter remain not yet be in operation for licensing purposes, but the SFC is continuously collecting OTC derivatives activity data and consulting on the FRR capital framework. The FRR amendments remain in the consultation or finalisation stage, and a final commencement date should not be assumed until the SFC publishes conclusions and the relevant subsidiary legislation is made.

For SFC-regulated groups, the main strategic issues are therefore no longer confined to legal classification. The practical questions are how client-facing functions, affiliate booking, HKTR data architecture, uncleared margin, risk mitigation controls and future capital charges interact in the target operating model. Firms that wait for formal commencement of every remaining licensing limb before reviewing booking arrangements, group-affiliate structures, data governance, documentation and capital allocation may find that the real commercial decisions have already been made for them by the architecture of the reform itself.